These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32964145)

  • 41. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.
    Atashi S; Izadi B; Jalilian S; Madani SH; Farahani A; Mohajeri P
    New Microbes New Infect; 2017 Sep; 19():117-120. PubMed ID: 28794886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of Mycobacterium tuberculosis (MTB) in Fecal Specimens From Adults Diagnosed With Pulmonary Tuberculosis Using the Xpert MTB/Rifampicin Test.
    Kokuto H; Sasaki Y; Yoshimatsu S; Mizuno K; Yi L; Mitarai S
    Open Forum Infect Dis; 2015 Apr; 2(2):ofv074. PubMed ID: 26125035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
    Yeboah-Manu D; Asante-Poku A; Bodmer T; Stucki D; Koram K; Bonsu F; Pluschke G; Gagneux S
    PLoS One; 2011; 6(7):e21906. PubMed ID: 21779354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis.
    Yadav RN; Kumar Singh B; Sharma R; Chaubey J; Sinha S; Jorwal P
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):237-244. PubMed ID: 33657709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.
    Bai W; Liu L; Wu L; Chen S; Wu S; Wang Z; Xu K; Chi Q; Pan Y; Xu X
    J Clin Lab Anal; 2022 Jan; 36(1):e24154. PubMed ID: 34850984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of the Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis.
    Tabriz NS; Skak K; Kassayeva LT; Omarkulov BK; Grigolashvili MA
    Microb Drug Resist; 2020 Aug; 26(8):997-1004. PubMed ID: 32181685
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic accuracy of Xpert MTB/RIF assay in extrapulmonary tuberculosis.
    Bankar S; Set R; Sharma D; Shah D; Shastri J
    Indian J Med Microbiol; 2018; 36(3):357-363. PubMed ID: 30429387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of GeneXpert MTB/RIF and conventional methods for the diagnosis of tuberculosis in Kosovo.
    Bajrami R; Mulliqi G; Kurti A; Lila G; Raka L
    J Infect Dev Ctries; 2016 Apr; 10(4):418-22. PubMed ID: 27131007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients.
    Rimal R; Shrestha D; Pyakurel S; Poudel R; Shrestha P; Rai KR; Ghimire GR; Rai G; Rai SK
    BMC Infect Dis; 2022 Apr; 22(1):321. PubMed ID: 35365080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.
    Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S
    BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Efficacy, Sensitivity, and Specificity of Xpert MTB/RIF Assay for Spinal Tuberculosis and Rifampicin Resistance.
    Patel J; Upadhyay M; Kundnani V; Merchant Z; Jain S; Kire N
    Spine (Phila Pa 1976); 2020 Feb; 45(3):163-169. PubMed ID: 31513101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.